Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/9183
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Russo, A. | - |
dc.contributor.author | Stevens, J. | - |
dc.contributor.author | Giles, N. | - |
dc.contributor.author | Krause, G. | - |
dc.contributor.author | O'Donovan, D. | - |
dc.contributor.author | Horowitz, M. | - |
dc.contributor.author | Jones, K. | - |
dc.date.issued | 2004 | - |
dc.identifier.citation | Alimentary Pharmacology and Therapeutics, 2004; 20(3):333-338 | - |
dc.identifier.issn | 0269-2813 | - |
dc.identifier.issn | 1365-2036 | - |
dc.identifier.uri | http://hdl.handle.net/2440/9183 | - |
dc.description | The definitive version is available at www.blackwell-synergy.com Article first published online: 9 JUL 2004 | - |
dc.description.abstract | Background: KC 11458, a motilin agonist without antibiotic properties, accelerates gastric emptying in animals and healthy humans. Aim: To evaluate the acute effects of KC 11458 on gastric emptying in diabetic gastroparesis. Methods: Twenty-nine patients (6 type 1 and 23 type 2) with gastroparesis underwent assessments of: (i) gastric emptying of a solid/liquid meal using scintigraphy, (ii) glycaemic control (blood glucose at 0, 30, 60, 90 and 120 min during the gastric emptying measurement) and (iii) upper gastrointestinal and ‘meal-related’ symptoms (questionnaire), at baseline and after treatment with KC 11458 in a dose of 8 mg t.d.s., or placebo for 8 days. Results: KC 11458 had no statistically significant or clinically relevant effect on gastric emptying of either the solid intragastric retention at 100 min (T100) (P ¼ 0.87) or liquid 50% emptying time (T50) (P ¼ 0.17) components of the meal. KC 11458 slightly worsened (P ¼ 0.04) upper gastrointestinal symptoms when compared with placebo. The magnitude of the change in solid gastric emptying correlated with the change in the blood glucose concentration (r ¼ 0.49; P < 0.05). Conclusions: KC 11458, in a dose of 8 mg t.d.s. for 8 days, does not accelerate gastric emptying in patients with diabetic gastroparesis. The absence of efficacy may relate to an effect of hyperglycaemia. | - |
dc.description.statementofresponsibility | A. Russo, J. E. Stevens, N. Giles, G. Krause, D. G. O’Donovan, M. Horowitz & K. L. Jones | - |
dc.language.iso | en | - |
dc.publisher | Blackwell Publishing Ltd | - |
dc.rights | © 2004 Blackwell Publishing Ltd | - |
dc.source.uri | http://dx.doi.org/10.1111/j.1365-2036.2004.02066.x | - |
dc.subject | Humans | - |
dc.subject | Gastroparesis | - |
dc.subject | Autonomic Nervous System Diseases | - |
dc.subject | Diabetic Neuropathies | - |
dc.subject | Diabetes Mellitus | - |
dc.subject | Erythromycin | - |
dc.subject | Motilin | - |
dc.subject | Blood Glucose | - |
dc.subject | Gastric Emptying | - |
dc.subject | Middle Aged | - |
dc.subject | Female | - |
dc.subject | Male | - |
dc.title | Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1111/j.1365-2036.2004.02066.x | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Horowitz, M. [0000-0002-0942-0306] | - |
dc.identifier.orcid | Jones, K. [0000-0002-1155-5816] | - |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.